Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Laryngoscope Investig Otolaryngol ; 7(5): 1675-1680, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36258870

ABSTRACT

Objectives: There is growing evidence that excess adipose tissue within the head and neck contributes to obstructive sleep apnea (OSA), particularly in obese patients. This subset of the population is often difficult to treat with surgical therapies. We theorized that a novel, transcervical method of injectable cryoablation using ice-slurry can achieve low temperatures without causing neurovascular damage or airway distress in a swine model. Methods: Four Yorkshire pigs were injected with ice-slurry comprised of normal saline and 10% glycerol cooled to -6°C via a transcervical, ultrasound guided approach. Direct laryngoscopy was used to confirm accurate placement of the slurry. Thermocouple placement at the needle-tip was used to measure temperatures at injection site. Swine were monitored for clinical signs of tongue necrosis and airway edema for 2 months, and then euthanized. Twelve biopsy samples from the base of the tongue were collected for histology. These were assessed for presence of tissue damage, inflammation and collagen formation by a blinded board-certified pathologist. Results: Tongue tissue temperature below 10°C was achieved for 13.5 ± 1.1 min. Minimum tissue temperature was -4 ± 0.6°C. There was no clinical or pathological evidence of tongue damage to include damage to the lingual nerve or artery. There was some histologic evidence of new collagen formation in areas of the tongue. Conclusions: Transcervical ultrasound-guided ice-slurry injection is feasible, well-tolerated at temperatures previously shown to be capable of selectively targeting adipose tissue in the base of the tongue in a preclinical swine model, without causing neurovascular damage or airway distress when properly injected.

2.
J Am Acad Dermatol ; 81(5): 1059-1069, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31610858

ABSTRACT

In light of the increasing prevalence of obesity, a large proportion of patients are taking weight loss medications or undergoing weight loss procedures. The typical paradigm for treating obesity begins with lifestyle interventions and progresses to medical treatments, and when nonsurgical interventions have failed, procedural techniques are considered. The effect of these interventions on the skin and dermatologic conditions has not been reviewed in depth. Herein, we review the impact of weight loss on pre-existing dermatologic conditions, as well as the development of novel skin changes and consequences of redundant skin after these interventions.


Subject(s)
Obesity/complications , Obesity/therapy , Skin Diseases/etiology , Weight Loss , Anti-Obesity Agents/adverse effects , Anti-Obesity Agents/therapeutic use , Bariatric Surgery/adverse effects , Cosmetic Techniques/adverse effects , Humans , Postoperative Complications/etiology
3.
Dermatol Clin ; 36(2): 123-126, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29499795

ABSTRACT

A variety of triggers are thought to exacerbate rosacea. A validated self-assessment tool and survey was used to study the relationship between rosacea severity and triggers. Subjects were adult patients with a clinical diagnosis of rosacea. Increased severity of disease was significantly associated with consumption of many alcoholic beverages in 1 day and employment at a job requiring extensive sun exposure. The authors' findings may inform physician counseling practices; patients may be provided with practical measures for managing their rosacea, such as limiting alcohol consumption over short periods of time and increasing sun protection, especially in the summer.


Subject(s)
Alcohol Drinking/adverse effects , Cigarette Smoking/adverse effects , Rosacea/etiology , Humans , Seasons , Severity of Illness Index , Sunlight/adverse effects , Surveys and Questionnaires
4.
Dermatol Clin ; 36(2): 135-150, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29499797

ABSTRACT

Papulopustular rosacea is characterized by papules and pustules in the central facial region. We review the literature surrounding the treatment of papulopustular rosacea. PubMed, EMBASE, and Cochrane (Central) databases searches of articles published from 1980 to 2015 were performed using the MeSH terms or keywords "rosacea" and "clinical trial." Additional searches were performed to include rosacea and each treatment modality used. Topical metronidazole, azelaic acid, ivermectin, and oral doxycycline have the most robust data to support their use. Variation in assessment tools and a lack of clinical trial standardization makes comparison of therapeutic options difficult.


Subject(s)
Anti-Infective Agents/therapeutic use , Dermatologic Agents/therapeutic use , Dicarboxylic Acids/therapeutic use , Doxycycline/therapeutic use , Ivermectin/therapeutic use , Metronidazole/therapeutic use , Rosacea/drug therapy , Administration, Cutaneous , Dicarboxylic Acids/administration & dosage , Humans , Ivermectin/administration & dosage , Metronidazole/administration & dosage
5.
Dermatol Clin ; 36(2): 167-170, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29499800

ABSTRACT

The recalcitrance of rosacea to many treatment options may prompt patients to spend exorbitant amounts of money on unsubstantiated treatment regimens in an effort to achieve relief. The authors examine the relationship between disease severity and treatment cost across several demographic and socioeconomic strata. Familiarization of evidence-based clinical recommendations and consensus guidelines may equip physicians to educate patients about the most efficacious and cost-effective treatment options to assist patients in making cost-conscious decisions in the management of their rosacea.


Subject(s)
Health Expenditures/statistics & numerical data , Income , Insurance, Health/economics , Rosacea/economics , Complementary Therapies/economics , Female , Humans , Male , Rosacea/therapy , Severity of Illness Index
6.
Dermatol Clin ; 36(2): 97-102, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29499805

ABSTRACT

Severity of rosacea in populations is not well characterized. A validated self-assessment tool was used to study the relationship between rosacea severity and demographic factors. Subjects were adult patients with a clinical diagnosis of rosacea. Self-assessment severity scores were significantly higher in participants less than 60 years old (mean 3.43 ± 1.07) compared with those greater than or equal to 60 years old (mean 3.09 ± 1.13; P = .04). Self-assessment severity scores were significantly higher in men (3.6 ± 1.3) than women (3.2 ± 1.0; P = .04). The authors conclude that rosacea is more severe in men and younger patients.


Subject(s)
Diagnostic Self Evaluation , Rosacea/epidemiology , Rosacea/therapy , Surveys and Questionnaires , Adult , Age Distribution , Age Factors , Aged , Aged, 80 and over , Comorbidity , Female , Humans , Male , Middle Aged , Prevalence , Rosacea/diagnosis , Self Care , Severity of Illness Index , Sex Distribution , Sex Factors , Time Factors , Young Adult
7.
J Clin Invest ; 127(1): 106-116, 2017 01 03.
Article in English | MEDLINE | ID: mdl-27869649

ABSTRACT

BACKGROUND: Actinic keratosis is a precursor to cutaneous squamous cell carcinoma. Long treatment durations and severe side effects have limited the efficacy of current actinic keratosis treatments. Thymic stromal lymphopoietin (TSLP) is an epithelium-derived cytokine that induces a robust antitumor immunity in barrier-defective skin. Here, we investigated the efficacy of calcipotriol, a topical TSLP inducer, in combination with 5-fluorouracil (5-FU) as an immunotherapy for actinic keratosis. METHODS: The mechanism of calcipotriol action against skin carcinogenesis was examined in genetically engineered mouse models. The efficacy and safety of 0.005% calcipotriol ointment combined with 5% 5-FU cream were compared with Vaseline plus 5-FU for the field treatment of actinic keratosis in a randomized, double-blind clinical trial involving 131 participants. The assigned treatment was self-applied to the entirety of the qualified anatomical sites (face, scalp, and upper extremities) twice daily for 4 consecutive days. The percentage of reduction in the number of actinic keratoses (primary outcome), local skin reactions, and immune activation parameters were assessed. RESULTS: Calcipotriol suppressed skin cancer development in mice in a TSLP-dependent manner. Four-day application of calcipotriol plus 5-FU versus Vaseline plus 5-FU led to an 87.8% versus 26.3% mean reduction in the number of actinic keratoses in participants (P < 0.0001). Importantly, calcipotriol plus 5-FU treatment induced TSLP, HLA class II, and natural killer cell group 2D (NKG2D) ligand expression in the lesional keratinocytes associated with a marked CD4+ T cell infiltration, which peaked on days 10-11 after treatment, without pain, crusting, or ulceration. CONCLUSION: Our findings demonstrate the synergistic effects of calcipotriol and 5-FU treatment in optimally activating a CD4+ T cell-mediated immunity against actinic keratoses and, potentially, cancers of the skin and other organs. TRIAL REGISTRATION: ClinicalTrials.gov NCT02019355. FUNDING: Not applicable (investigator-initiated clinical trial).


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Keratosis, Actinic/drug therapy , Precancerous Conditions/drug therapy , Skin Neoplasms/drug therapy , Administration, Topical , Aged , Aged, 80 and over , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , Calcitriol/administration & dosage , Calcitriol/analogs & derivatives , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/pathology , Cytokines/genetics , Cytokines/immunology , Female , Fluorouracil/administration & dosage , Humans , Immunity, Cellular/drug effects , Immunity, Cellular/genetics , Keratosis, Actinic/genetics , Keratosis, Actinic/immunology , Keratosis, Actinic/pathology , Male , Mice , Mice, Transgenic , Middle Aged , Precancerous Conditions/genetics , Precancerous Conditions/immunology , Precancerous Conditions/pathology , Skin Neoplasms/genetics , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Thymic Stromal Lymphopoietin
8.
Dermatol Online J ; 20(9)2014 Sep 16.
Article in English | MEDLINE | ID: mdl-25244178

ABSTRACT

Atopic dermatitis is a very common chronic skin disease. With increasing number of patients searching social media outlets such as Facebook for medical information, social media can be used by physicians as a powerful educational tool. We analyzed the unmoderated Q&A series on Facebook begun by members of National Eczema Association Scientific Advisory Committee. Four respondents accounted for more than 50% of all responses and the most common were negative posts about topical steroids (61%). Possible strategies to accomplish the safe dissemination of information in a public forum may include a moderator role for physicians.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Dermatitis, Atopic/drug therapy , Patient Education as Topic , Social Media , Administration, Cutaneous , Adrenal Cortex Hormones/administration & dosage , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...